These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 530511)

  • 21. Thought, language, and communication in schizophrenia: diagnosis and prognosis.
    Andreasen NC; Grove WM
    Schizophr Bull; 1986; 12(3):348-59. PubMed ID: 3764356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.
    Sokol DK; O'Brien RS; Wagenknecht DR; Rao T; McIntyre JA
    J Neuroimmunol; 2007 Oct; 190(1-2):151-6. PubMed ID: 17868908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of cigarette-induced increase in serum nicotine levels with arginine vasopressin concentrations in the syndrome of self-induced water intoxication and psychosis (SIWIP).
    Vieweg WV; David JJ; Rowe WT; Peach MJ; Veldhuis JD; Spradlin WW
    Can J Psychiatry; 1986 Mar; 31(2):108-11. PubMed ID: 3697900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nyctohemeral rhythm of plasma cortisol in mental illness in Nigerians.
    Adadevoh BK; Asuni T
    Br J Psychiatry; 1973 Jul; 123(572):107-8. PubMed ID: 4729866
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor increase during treatment in severe mental illness inpatients.
    Nuernberg GL; Aguiar B; Bristot G; Fleck MP; Rocha NS
    Transl Psychiatry; 2016 Dec; 6(12):e985. PubMed ID: 27959329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders.
    Emanuele E; Martinelli V; Carlin MV; Fugazza E; Barale F; Politi P
    Neurosci Lett; 2011 Jan; 487(1):99-102. PubMed ID: 20937362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
    Kaiya H; Tamura Y; Adachi S; Moriuchi I; Namba M; Tanaka M; Yoshida H; Yanaihara N; Yanaihara C
    Psychiatry Res; 1981 Aug; 5(1):11-21. PubMed ID: 6169105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal fragile site expression in Turkish psychiatric patients.
    Taştemir D; Demirhan O; Sertdemir Y
    Psychiatry Res; 2006 Nov; 144(2-3):197-203. PubMed ID: 17007939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional hormonal discrimination of paranoid schizophrenic from bipolar manic patients.
    Mason JW; Kosten TR; Giller EL
    Biol Psychiatry; 1991 Mar; 29(5):457-66. PubMed ID: 2018819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism.
    Banki CM
    Acta Psychiatr Scand; 1978 Mar; 57(3):232-8. PubMed ID: 645413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin and schizophrenia: no evidence of an association.
    Linkowski P; Staroukine M; Verniory A; Mendlewicz J
    Commun Psychopharmacol; 1979; 3(2):67-8. PubMed ID: 467003
    [No Abstract]   [Full Text] [Related]  

  • 32. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.
    Huang TL; Lee CT
    J Psychiatr Res; 2006 Oct; 40(7):664-8. PubMed ID: 16386272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creatine kinase and aldolase in serum: abnormality common to acute psychoses.
    Meltzer H
    Science; 1968 Mar; 159(3821):1368-70. PubMed ID: 5644267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses.
    Kendler KS; Davis KL
    Schizophr Bull; 1981; 7(4):689-709. PubMed ID: 7034192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ON ENDOGENOUS PSYCHOSES. (CLINICAL OBSERVATIONS OF THE PROBLEM OF "RELEASE")].
    WEITBRECHT HJ
    Nervenarzt; 1964 Dec; 35():521-9. PubMed ID: 14339786
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of the clinical characteristics of manic, manic- paranoid and manic-hebephrenic conditions for differentiated psychopharmacotherapy].
    Mosolov SN; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):87-93. PubMed ID: 2750391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E; Shopsin B; Sathananthan G; Gershon S
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract]   [Full Text] [Related]  

  • 38. ABO blood group distribution in hebephrenic and paranoid schizophrenics. Preliminary data.
    Maj M; Morgese G; Del Vecchio M; Kemali D
    Acta Neurol (Napoli); 1980 Oct; 2(5):394-8. PubMed ID: 7457218
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum glycoconjugates in children with schizophrenia and conduct and adjustment disorders.
    Varma R; Michos GA; Gordon BJ; Varma RS; Shirey RE
    Biochem Med; 1983 Oct; 30(2):206-14. PubMed ID: 6651790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid function screening in new psychiatric admissions.
    Morley JE; Shafer RB
    Arch Intern Med; 1982 Mar; 142(3):591-3. PubMed ID: 7065794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.